KATHERINE PENCE: Open Payments
NPI 1598207359 · CHARLOTTESVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$816 in 36 payments from 9 companies in 2025. Trend: 2023 $644 · 2024 $931 · 2025 $816
Food & beverage: $816
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $433 |
| Janssen Biotech, Inc. | 2 | $125 |
| Gilead Sciences, Inc. | 3 | $85 |
| Novo Nordisk Inc | 2 | $76 |
| Phathom Pharmaceuticals, Inc. | 2 | $25 |
| Lilly USA, LLC | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Medtronic, Inc. | 1 | $18 |
| Ardelyx, Inc. | 1 | $14 |
Products named: RINVOQ, TREMFYA, CREON, Wegovy, SKYRIZI, VOQUEZNA, OMVOH, ZENPEP.
Industry payments across VA — which companies pay providers there.
